515 related articles for article (PubMed ID: 10630565)
1. Ethical review of regulatory toxicology guidelines involving experiments on animals: the example of endocrine disrupters.
Purchase IF
Toxicol Sci; 1999 Dec; 52(2):141-7. PubMed ID: 10630565
[TBL] [Abstract][Full Text] [Related]
2. FIFRA Subdivision F testing Guidelines: are these tests adequate to detect potential hormonal activity for crop protection chemicals? Federal Insecticide, Fungicide, and Rodenticide Act.
Stevens JT; Tobia A; Lamb JC; Tellone C; O'Neal F
J Toxicol Environ Health; 1997 Apr; 50(5):415-31. PubMed ID: 9140462
[TBL] [Abstract][Full Text] [Related]
3. Uncertainties for endocrine disrupters: our view on progress.
Daston GP; Cook JC; Kavlock RJ
Toxicol Sci; 2003 Aug; 74(2):245-52. PubMed ID: 12730617
[TBL] [Abstract][Full Text] [Related]
4. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
Box RJ; Spielmann H
Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
[TBL] [Abstract][Full Text] [Related]
5. Fighting trafficking of falsified and substandard medicinal products in Russia.
Fayzrakhmanov NF
Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
[TBL] [Abstract][Full Text] [Related]
6. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Tier I screening approaches for detecting endocrine-active compounds (EACs).
O'Connor JC; Cook JC; Marty MS; Davis LG; Kaplan AM; Carney EW
Crit Rev Toxicol; 2002; 32(6):521-49. PubMed ID: 12487364
[TBL] [Abstract][Full Text] [Related]
8. Animal use in the safety evaluation of chemicals: harmonization and emerging needs.
Spielmann H
ILAR J; 2002; 43 Suppl():S11-7. PubMed ID: 12388845
[TBL] [Abstract][Full Text] [Related]
9. Toxicogenomic approach to endocrine disrupters: identification of a transcript profile characteristic of chemicals with estrogenic activity.
Naciff JM; Daston GP
Toxicol Pathol; 2004; 32 Suppl 2():59-70. PubMed ID: 15503665
[TBL] [Abstract][Full Text] [Related]
10. Risk assessment of endocrine active chemicals: identifying chemicals of regulatory concern.
Bars R; Fegert I; Gross M; Lewis D; Weltje L; Weyers A; Wheeler JR; Galay-Burgos M
Regul Toxicol Pharmacol; 2012 Oct; 64(1):143-54. PubMed ID: 22735369
[TBL] [Abstract][Full Text] [Related]
11. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
[TBL] [Abstract][Full Text] [Related]
12. A review of mammalian carcinogenicity study design and potential effects of alternate test procedures on the safety evaluation of food ingredients.
Hayes AW; Dayan AD; Hall WC; Kodell RL; Williams GM; Waddell WD; Slesinski RS; Kruger CL
Regul Toxicol Pharmacol; 2011 Jun; 60(1 Suppl):S1-34. PubMed ID: 21094668
[TBL] [Abstract][Full Text] [Related]
13. Alternatives to animal experimentation in basic research.
Gruber FP; Hartung T
ALTEX; 2004; 21 Suppl 1():3-31. PubMed ID: 15586255
[TBL] [Abstract][Full Text] [Related]
14. Report from the BfR expert hearing on practicability of hormonal measurements: recommendations for experimental design of toxicological studies with integrated hormonal end points.
Kucheryavenko O; Lurman G; Lehmann A; Braz J; Niemann L; Chahoud I; Mantovani A; Håkansson H; Schneider S; Strauss V; Coder PS; Freyberger A; O'Connor JC; Rauch M; Renko K; Solano MLM; Andersson N; Blanck O; Ritz V; Solecki R
Arch Toxicol; 2019 Apr; 93(4):1157-1167. PubMed ID: 30929029
[TBL] [Abstract][Full Text] [Related]
15. Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: a workshop summary.
Boverhof DR; Ladics G; Luebke B; Botham J; Corsini E; Evans E; Germolec D; Holsapple M; Loveless SE; Lu H; van der Laan JW; White KL; Yang Y
Regul Toxicol Pharmacol; 2014 Feb; 68(1):96-107. PubMed ID: 24280359
[TBL] [Abstract][Full Text] [Related]
16. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
[TBL] [Abstract][Full Text] [Related]
17. Endocrine disruptors: a critical review of in vitro and in vivo testing strategies for assessing their toxic hazard to humans.
Combes RD
Altern Lab Anim; 2000; 28(1):81-118. PubMed ID: 25406107
[TBL] [Abstract][Full Text] [Related]
18. Endocrine disrupting chemicals research program of the U.S. Environmental Protection Agency: summary of a peer-review report.
Harding AK; Daston GP; Boyd GR; Lucier GW; Safe SH; Stewart J; Tillitt DE; Van Der Kraak G
Environ Health Perspect; 2006 Aug; 114(8):1276-82. PubMed ID: 16882539
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
